Skip to main content
ALLMM
Online First
Original Research, Adverse Events, Pediatric Cancer, Acute Lymphoblastic Leukemia
Impact of Universal Pegaspargase Premedication on Substitution Rates and Adverse Events
Jordan Wallace, PharmD, BCOP; Taylor Dennison, PharmD, BCOP; Jess Auten, PharmD, BCOP; Carmen Echols, PharmD, BCPPS; Kynlon Phillips, PharmD, BCPS, BCOP; Jenna Bognaski Kaplan, PharmD, BCPPS
Read More
Online First
Original Research, Acute Lymphoblastic Leukemia, Anticoagulants, Thromboembolism
Evaluation of Clotting and Bleeding Risk Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia
Alyssa Cendagorta, PharmD, BCOP; Frank Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Kristen O’Dwyer, MD; Andrea Baran, MS; Nicole M. Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Carissa Treptow, PharmD, BCOP
Read More
Acute Lymphoblastic Leukemia
Cytokine Release Syndrome Associated with Treatment for Acute Lymphoblastic Leukemia
Read More
Acute Lymphoblastic Leukemia
Treatment-Associated Neurotoxicity in Patients with Acute Lymphoblastic Leukemia
Read More
Acute Lymphoblastic Leukemia
Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia
Read More
Acute Lymphoblastic Leukemia
Roles and Responsibilities of the Multidisciplinary Care Team in Acute Lymphoblastic Leukemia
Read More
Acute Lymphoblastic Leukemia
Transition of Care for Patients with Acute Lymphoblastic Leukemia
Read More
Case Reports, Acute Lymphoblastic Leukemia, Leukemia, Adverse Events
Pegaspargase-Induced Diabetic Ketoacidosis in a Patient with Acute Lymphoblastic Leukemia
Ellen Madarang, PharmD, BCOP, Leslie Gallardo, PharmD, BCPS, Terrence Bradley, MD
Ellen Madarang, PharmD, BCOP; Leslie Gallardo, PharmD, BCPS; Terrence Bradley, MD
Read More

Results 1 - 8 of 8